Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Neurology|August 19, 2004
Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findingsB Meissner, K Körtner, M Bartl, et al.Proceedings of the National Academy of Sciences of the United States of America|May 11, 2016
NLRC5/MHC class I transactivator is a target for immune evasion in cancerSayuri Yoshihama, Jason Roszik, Isaac Downs, et al.Proceedings of the National Academy of Sciences of the United States of America|July 20, 2010
NLR family member NLRC5 is a transcriptional regulator of MHC class I genesTorsten B Meissner, Amy Li, Amlan Biswas, et al.Bone Marrow Transplantation|October 14, 2008
Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005M Sauer, B Meissner, D Fuchs, et al.Neurology|October 14, 2005
Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 typeB Meissner, I M Westner, K Kallenberg, et al.Brain : a Journal of Neurology|May 3, 2007
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillanceU Heinemann, A Krasnianski, B Meissner, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expressionTorsten B Meissner, Yuen-Joyce Liu, Kyoung-Hee Lee, et al.Current Oncology (Toronto, Ont.)|November 3, 2016
A time-and-motion approach to micro-costing of high-throughput genomic assaysS Costa, D A Regier, B Meissner, et al.European Journal of Neurology|August 8, 2008
MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement studyA Krasnianski, K Kallenberg, D A Collie, et al.Journal of Neurology|January 23, 2009
MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob diseaseB Meissner, K Kallenberg, P Sanchez-Juan, et al.Pageof 5